Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests preemptive migraine pill for known triggers

NCT ID NCT07301008

First seen Jan 08, 2026 · Last updated May 23, 2026 · Updated 17 times

Summary

This study tests if taking rimegepant before a known trigger (like exercise, alcohol, or stress) can prevent a migraine from starting. 60 adults with migraine will take the pill before their trigger and report if a headache occurs within 24 hours. The goal is to see if preemptive treatment reduces moderate-to-severe migraines.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIGRAINE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • MedStar Health: Neurology at McLean

    RECRUITING

    McLean, Virginia, 22101, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.